Take the Chance
How to Become a UICC President
PATINA: Major FDA–EMA Divide Over Palbociclib in HER2+ Breast Cancer
What’s New On Radiotherapy of Lung Cancer in 2026?
PharmaMar as a Foundational Partner of OncoDaily Grand Rounds at ESMO 2026: Sarcoma Edition
The Promise on Hold: Takeda and Pfizer still to respond to help a Nigerian child with Hodgkin Lymphoma
Follicular Lymphoma: EHA 2026 Guidelines Move Chemotherapy-Free Combinations to First Relapse
ALICE Trial at IGCS 2026: Reduced Surgical Morbidity in Endometrial Cancer Staging
The ALRCaN Global webinar, “Treatment Strategy for a 4-Year-Old Boy with Newly Diagnosed MLL-AF4-Positive B-ALL,” is set for Friday, April 24, 2026, from 09:00 AM to 10:00 AM ET (05:00 PM – 06:00 PM AMT). Led by Dr. Hisato Segoe, this session examines specialized clinical approaches for high-risk pediatric leukemia subtypes. Organized by the Acute […]
The 2026 IOTOX Symposium: Delivering What Matters - Patient-Centered through IOTOX Translational Science, organized by The University of Texas MD Anderson Cancer Center, is a hybrid educational event scheduled from Friday, April 24, to Saturday, April 25, 2026. This symposium is dedicated to bridging the gap between translational science and clinical practice, offering healthcare professionals […]
Harvesting Knowledge: A Summit on Multiple Myeloma is a specialized, one-day clinical program taking place on April 25, 2026, in Napa, California. Organized by Bio Ascend, this summit is designed to equip hematologists, oncologists, and nursing professionals with evidence-based strategies for managing multiple myeloma throughout the entire patient journey. The hybrid event features "State of […]
The European Conference on Interventional Oncology (ECIO) 2026 is the leading multidisciplinary platform for minimally invasive cancer care. Scheduled for April 26–30, 2026, the event will take place at the Congress Center Basel in Basel, Switzerland. Organized by the Cardiovascular and Interventional Radiological Society of Europe (CIRSE), the conference highlights interventional oncology (IO) as the […]
Celebrating its 20th landmark edition, the 20th International p53 Workshop arrives in Toronto from April 27 to May 1, 2026, to explore the frontier of the most frequently mutated gene in human cancer. Co-organized by Canada’s leading research powerhouses—University Health Network (UHN), the Lunenfeld-Tanenbaum Research Institute, and SickKids—this globally recognized summit gathers the world’s elite […]
The Community Oncology Conference 2026, organized by the Community Oncology Alliance (COA), will take place on April 28–29, 2026, at the Walt Disney World Dolphin Resort in Lake Buena Vista, Florida, USA. As the leading annual event for the field, the conference's core focus is equipping community oncologists and their teams with the necessary knowledge […]
The Thoracic Oncology Group of Australasia (TOGA) will host the interactive webinar "Beyond the NGS Report" on Tuesday, April 28, 2026, from 6:30 pm to 8:00 pm AEDT. Specifically designed […]
The ESMO Guidelines: Real World Cases - Webinar Series: Bladder Cancer 2026 is a specialized virtual scientific meeting scheduled for April 29, 2026, focused on translating the latest ESMO Clinical Practice Guidelines into clinical practice. Chaired by Andrea Necchi, the webinar addresses the rapidly evolving landscape of bladder cancer management, including the integration of immune […]
The ALIGN 2026: Advancing Learning and Innovation in Goal Concordant Care conference is an interdisciplinary scientific meeting scheduled for April 29–30, 2026, in Houston, Texas. Organized by The University of Texas MD Anderson Cancer Center, the symposium focuses on optimizing oncological care by aligning medical treatments with individual patient values, preferences, and goals. The program […]
Closing out Head and Neck Cancers Awareness Month, the How I Treat Head and Neck Cancers in 2026: OncoDaily Virtual Summit addresses a disease group responsible for over 890,000 new […]
The 2026 Highlights of ASH in Latin America is a two-day program scheduled for May 1–2, 2026, in Bogotá, Colombia, at the Grand Hyatt Bogotá. Organized by the American Society of Hematology (ASH) in collaboration with the Colombian Association of Hematology and Oncology (ACHO), the meeting is designed for hematologists, oncologists, and related professionals to […]
The APPOS Washington DC 2026 (Advanced Practice Providers Oncology Summit) is a two-day continuing education conference tailored for advanced practice providers (APPs), including NPs, PAs, pharmacists, and nurses, as well as the entire multidisciplinary oncology team. The event is scheduled for May 1–2, 2026, and will be held at the Hyatt Regency Washington on Capitol […]
The 13th Cholangiocarcinoma Foundation Annual Conference, with the theme "Strength in Community: Every Patient Counts," will take place from May 1–3, 2026, in Salt Lake City, Utah. The event is hosted by the Cholangiocarcinoma Foundation and will convene a global community of leading researchers, clinicians, patients, caregivers, and advocates. Its purpose is to explore the […]
The Cancer Care and Prevention Symposium 2026, presented by Ironwood Cancer and Research Centers and Horizon CME, is a multidisciplinary conference scheduled for May 2, 2026, at The Westin Kierland Resort in Scottsdale, Arizona. The symposium is designed for a broad audience of healthcare professionals, including primary care providers and various oncologists, to discuss the […]
ANCO's Hematologic Malignancies Update 2026, held May 2–3, 2026, at the Hyatt Regency Monterey, will provide clinicians, nurses, nurse practitioners, and physician assistants with the latest advances in the treatment of hematologic malignancies. The two-day meeting features expert-led sessions on clinically relevant topics to support evidence-based practice in hematology and oncology.
The ESMO Deep Dive: Genitourinary Cancers: Improving Outcomes in High-Risk Localized Prostate Cancer 2026 is a virtual scientific webinar scheduled for May 6, 2026. This session focuses on the clinical management of high-risk localized prostate cancer, a disease state associated with significant risks of recurrence and mortality. Chaired by Deborah Mukherji, the program features technical […]
